Header Logo

Connection

Mark Pollack to Dose-Response Relationship, Drug

This is a "connection" page, showing publications Mark Pollack has written about Dose-Response Relationship, Drug.
  1. Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation. Behav Res Ther. 2010 Aug; 48(8):720-7.
    View in: PubMed
    Score: 0.083
  2. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies. J Clin Psychopharmacol. 2008 Jun; 28(3):308-16.
    View in: PubMed
    Score: 0.073
  3. Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings. Psychopharmacology (Berl). 2008 May; 197(4):675-81.
    View in: PubMed
    Score: 0.071
  4. A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder. Psychopharmacology (Berl). 2007 Oct; 194(2):233-42.
    View in: PubMed
    Score: 0.068
  5. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder. Depress Anxiety. 2007; 24(1):1-14.
    View in: PubMed
    Score: 0.066
  6. Benzodiazepines in clinical practice: consideration of their long-term use and alternative agents. J Clin Psychiatry. 2005; 66 Suppl 2:21-7.
    View in: PubMed
    Score: 0.057
  7. Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial. Psychopharmacology (Berl). 2005 Jan; 177(3):280-8.
    View in: PubMed
    Score: 0.056
  8. Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder. J Psychiatr Res. 2002 Jul-Aug; 36(4):229-36.
    View in: PubMed
    Score: 0.048
  9. Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication. J Clin Psychopharmacol. 2000 Dec; 20(6):622-7.
    View in: PubMed
    Score: 0.043
  10. Adjunctive yohimbine for treatment in refractory depression. Biol Psychiatry. 1993 Feb 01; 33(3):220-1.
    View in: PubMed
    Score: 0.025
  11. Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial. J Clin Psychiatry. 2012 Mar; 73(3):353-7.
    View in: PubMed
    Score: 0.023
  12. Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder. CNS Spectr. 2008 Jun; 13(6):522-7.
    View in: PubMed
    Score: 0.018
  13. Propranolol and depression revisited: three cases and a review. J Nerv Ment Dis. 1985 Feb; 173(2):118-9.
    View in: PubMed
    Score: 0.014
  14. Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder. Psychol Med. 2003 Apr; 33(3):511-8.
    View in: PubMed
    Score: 0.013
  15. Pseudomonas aeruginosa exotoxin A inhibits proliferation of human bone marrow progenitor cells in vitro. Infect Immun. 1982 Oct; 38(1):206-11.
    View in: PubMed
    Score: 0.012
  16. Strategies for treatment of SSRI-associated sexual dysfunction: a survey of an academic psychopharmacology practice. Harv Rev Psychiatry. 2002 Mar-Apr; 10(2):109-14.
    View in: PubMed
    Score: 0.012
  17. Sertraline treatment of panic disorder: results of a long-term study. Acta Psychiatr Scand. 2001 Oct; 104(4):289-98.
    View in: PubMed
    Score: 0.011
  18. Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine. The Fluoxetine Panic Disorder Study Group. Br J Psychiatry. 1999 Mar; 174:213-8.
    View in: PubMed
    Score: 0.010
  19. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group. Am J Psychiatry. 1998 Nov; 155(11):1570-7.
    View in: PubMed
    Score: 0.009
  20. Moclobemide in social phobia: a controlled dose-response trial. J Clin Psychopharmacol. 1997 Aug; 17(4):247-54.
    View in: PubMed
    Score: 0.009
  21. The relationship of alprazolam and clonazepam dose to steady-state concentration in plasma. J Clin Psychopharmacol. 1994 Aug; 14(4):274-6.
    View in: PubMed
    Score: 0.007
  22. The antidepressant potential of oral S-adenosyl-l-methionine. Acta Psychiatr Scand. 1990 May; 81(5):432-6.
    View in: PubMed
    Score: 0.005
  23. A prospective double-blind study of side effects associated with the administration of amantadine for influenza A virus prophylaxis. J Infect Dis. 1980 May; 141(5):543-7.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.